BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7514779)

  • 1. Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy.
    Ransom MX; Garcia AJ; Bohrer M; Corsan GH; Kemmann E
    Obstet Gynecol; 1994 Jun; 83(6):1033-7. PubMed ID: 7514779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.
    Saraj AJ; Wilcox JG; Najmabadi S; Stein SM; Johnson MB; Paulson RJ
    Obstet Gynecol; 1998 Dec; 92(6):989-94. PubMed ID: 9840564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubal pregnancies: early pregnancy factor, progesterone, beta-HCG and vaginal sonography as differential diagnostic parameters].
    Mesrogli M; Degenhardt F; Maas DH; Klaus I; Busche M; Schneider J
    Z Geburtshilfe Perinatol; 1988; 192(3):130-2. PubMed ID: 2463715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of residual ectopic pregnancy: RU 486 and methotrexate.
    Kenigsberg D; Porte J; Hull M; Spitz IM
    Fertil Steril; 1987 Apr; 47(4):702-3. PubMed ID: 2436953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ectopic pregnancy by transvaginal intratubal methotrexate administration.
    Tulandi T; Bret PM; Atri M; Senterman M
    Obstet Gynecol; 1991 Apr; 77(4):627-30. PubMed ID: 2002990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising beta-hCG titres following laparoscopic injection of methotrexate into unruptured, viable tubal pregnancies.
    Groutz A; Luxman D; Cohen JR; David MP
    Br J Obstet Gynaecol; 1993 Mar; 100(3):287-8. PubMed ID: 7682841
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of methotrexate treatment failure in ectopic pregnancy.
    Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
    J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
    Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
    Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.
    Wong L; Fung LWY; Cheung CW; Lao TT
    Int J Gynaecol Obstet; 2018 May; 141(2):245-249. PubMed ID: 29214643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of ectopic pregnancy by means of a single injection of methotrexate into the gestational sac.
    Venezia R; Zangara C
    Acta Eur Fertil; 1989; 20(4):227-30. PubMed ID: 2485123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of ectopic pregnancy and its effect on corpus luteum activity.
    Shulman A; Maymon R; Zmira N; Lotan M; Holtzinger M; Bahary C
    Gynecol Obstet Invest; 1992; 33(3):161-4. PubMed ID: 1377160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus luteum activity in tubal pregnancy.
    Sauer MV; Gorrill MJ; Rodi IA; Yeko TR; Buster JE
    Obstet Gynecol; 1988 May; 71(5):667-70. PubMed ID: 3357652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tubal pregnancy with methotrexate.
    Zakut H; Sadan O; Katz A; Dreval D; Bernstein D
    Br J Obstet Gynaecol; 1989 Jun; 96(6):725-8. PubMed ID: 2478186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.
    Lipscomb GH; McCord ML; Stovall TG; Huff G; Portera SG; Ling FW
    N Engl J Med; 1999 Dec; 341(26):1974-8. PubMed ID: 10607814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy.
    Corsan GH; Karacan M; Qasim S; Bohrer MK; Ransom MX; Kemmann E
    Hum Reprod; 1995 Oct; 10(10):2719-22. PubMed ID: 8567799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy.
    Carson SA; Stovall T; Umstot E; Andersen R; Ling F; Buster JE
    Fertil Steril; 1989 Apr; 51(4):593-7. PubMed ID: 2466704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of unruptured tubal pregnancy by local injection of methotrexate under transvaginal sonographic control.
    Ménard A; Créquat J; Mandelbrot L; Hauuy JP; Madelenat P
    Fertil Steril; 1990 Jul; 54(1):47-50. PubMed ID: 1694146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent tubal ectopic gestation: patterns of circulating beta-human chorionic gonadotropin and progesterone, and management options.
    Vermesh M; Silva PD; Sauer MV; Vargyas JM; Lobo RA
    Fertil Steril; 1988 Oct; 50(4):584-8. PubMed ID: 2458973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotrophin in screening for ectopic pregnancy.
    Stovall TG; Ling FW; Andersen RN; Buster JE
    Hum Reprod; 1992 May; 7(5):723-5. PubMed ID: 1379268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic pregnancy: evolution after treatment with transvaginal methotrexate.
    Atri M; Bret PM; Tulandi T; Senterman MK
    Radiology; 1992 Dec; 185(3):749-53. PubMed ID: 1279740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.